Jump Financial, LLC Neurocrine Biosciences Inc Transaction History

Jump Financial, LLC

  • $4.3 Billion
  • Q4 2024

A detailed history of Jump Financial, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Jump Financial, LLC holds 1,676 shares of NBIX stock, worth $190,812. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,676
Previous 40,754 95.89%
Holding current value
$190,812
Previous $4.69 Million 95.14%
% of portfolio
0.01%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $4.36 Million - $5.45 Million
-39,078 Reduced 95.89%
1,676 $228,000
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $4.67 Million - $6.24 Million
40,754 New
40,754 $4.69 Million
Q4 2023

Oct 21, 2024
BUY
$106.07 - $132.76 $957,069 - $1.2 Million
9,023 Added 114.48%
16,905 $2.23 Million
Q4 2023

Feb 07, 2024
BUY
$106.07 - $132.76 $957,069 - $1.2 Million
9,023 Added 114.48%
16,905 $2.23 Million
Q3 2023

Oct 21, 2024
SELL
$94.02 - $117.1 $217,938 - $271,437
-2,318 Reduced 22.73%
7,882 $886,000
Q3 2023

Nov 07, 2023
BUY
$94.02 - $117.1 $741,065 - $922,982
7,882 New
7,882 $886,000
Q1 2023

Oct 21, 2024
BUY
$94.11 - $123.02 $959,922 - $1.25 Million
10,200 New
10,200 $1.03 Million
Q1 2023

May 03, 2023
SELL
$94.11 - $123.02 $3.4 Million - $4.44 Million
-36,122 Reduced 77.98%
10,200 $1.03 Million
Q4 2022

Feb 13, 2023
SELL
$106.72 - $127.06 $1.16 Million - $1.38 Million
-10,878 Reduced 19.02%
46,322 $5.53 Million
Q3 2022

Nov 07, 2022
BUY
$92.03 - $107.81 $5.26 Million - $6.17 Million
57,200 New
57,200 $6.08 Million
Q4 2020

Feb 12, 2021
SELL
$86.91 - $108.33 $410,649 - $511,859
-4,725 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$96.16 - $135.15 $454,356 - $638,583
4,725 New
4,725 $455,000

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email